Cargando…

Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN

At present, it is relevant to preserve and raise healthy, well-developed newborn animals adapted to new conditions, which form the basis for increasing the yield of animal husbandry. Gastrointestinal diseases cause the main losses of young animals. Acute gastrointestinal diseases of calves, lambs, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Biyashev, Birzhan, Biyashev, Kadyr, Bulegenova, Madina, Kirkimbaeva, Zhumagul, Zhylkaidar, Arman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Carol Davila University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852633/
https://www.ncbi.nlm.nih.gov/pubmed/35186132
http://dx.doi.org/10.25122/jml-2021-0118
_version_ 1784653079939907584
author Biyashev, Birzhan
Biyashev, Kadyr
Bulegenova, Madina
Kirkimbaeva, Zhumagul
Zhylkaidar, Arman
author_facet Biyashev, Birzhan
Biyashev, Kadyr
Bulegenova, Madina
Kirkimbaeva, Zhumagul
Zhylkaidar, Arman
author_sort Biyashev, Birzhan
collection PubMed
description At present, it is relevant to preserve and raise healthy, well-developed newborn animals adapted to new conditions, which form the basis for increasing the yield of animal husbandry. Gastrointestinal diseases cause the main losses of young animals. Acute gastrointestinal diseases of calves, lambs, piglets, and chickens are widespread in Kazakhstan. The study aims to develop a competitive treatment and prophylactic drug composition based on probiotic bacterial strains. Modern certified and standardized biochemical, microbiological, molecular biological studies were considered during the research. The morphological, cultural, and biochemical properties of the cultures were studied according to generally accepted schemes. Standard methods of finding averages and their mean errors were used for the mathematical processing of results. Antibiotics, sulfonamide, and nitrofuran drugs are the most common methods to combat diseases in young animals. However, the use of antibacterial agents often leads to the death of normal microflora, disrupting the microbiocenosis of the gastrointestinal tract, the appearance of microorganisms with resistance to drugs, and a decrease in product quality. In this regard, the direction of biotechnology involved in the development and creation of environmentally friendly microbial preparations with prophylactic effectiveness is very relevant. Data on the prophylactic and therapeutic efficacy of the probiotic strain of Escherichia coli 39-SN are presented.
format Online
Article
Text
id pubmed-8852633
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Carol Davila University Press
record_format MEDLINE/PubMed
spelling pubmed-88526332022-03-01 Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN Biyashev, Birzhan Biyashev, Kadyr Bulegenova, Madina Kirkimbaeva, Zhumagul Zhylkaidar, Arman J Med Life Original Article At present, it is relevant to preserve and raise healthy, well-developed newborn animals adapted to new conditions, which form the basis for increasing the yield of animal husbandry. Gastrointestinal diseases cause the main losses of young animals. Acute gastrointestinal diseases of calves, lambs, piglets, and chickens are widespread in Kazakhstan. The study aims to develop a competitive treatment and prophylactic drug composition based on probiotic bacterial strains. Modern certified and standardized biochemical, microbiological, molecular biological studies were considered during the research. The morphological, cultural, and biochemical properties of the cultures were studied according to generally accepted schemes. Standard methods of finding averages and their mean errors were used for the mathematical processing of results. Antibiotics, sulfonamide, and nitrofuran drugs are the most common methods to combat diseases in young animals. However, the use of antibacterial agents often leads to the death of normal microflora, disrupting the microbiocenosis of the gastrointestinal tract, the appearance of microorganisms with resistance to drugs, and a decrease in product quality. In this regard, the direction of biotechnology involved in the development and creation of environmentally friendly microbial preparations with prophylactic effectiveness is very relevant. Data on the prophylactic and therapeutic efficacy of the probiotic strain of Escherichia coli 39-SN are presented. Carol Davila University Press 2022-01 /pmc/articles/PMC8852633/ /pubmed/35186132 http://dx.doi.org/10.25122/jml-2021-0118 Text en ©2022 JOURNAL of MEDICINE and LIFE https://creativecommons.org/licenses/by/3.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Original Article
Biyashev, Birzhan
Biyashev, Kadyr
Bulegenova, Madina
Kirkimbaeva, Zhumagul
Zhylkaidar, Arman
Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
title Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
title_full Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
title_fullStr Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
title_full_unstemmed Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
title_short Determination of prophylactic and therapeutic effectiveness of probiotic strain Escherichia coli 39-SN
title_sort determination of prophylactic and therapeutic effectiveness of probiotic strain escherichia coli 39-sn
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852633/
https://www.ncbi.nlm.nih.gov/pubmed/35186132
http://dx.doi.org/10.25122/jml-2021-0118
work_keys_str_mv AT biyashevbirzhan determinationofprophylacticandtherapeuticeffectivenessofprobioticstrainescherichiacoli39sn
AT biyashevkadyr determinationofprophylacticandtherapeuticeffectivenessofprobioticstrainescherichiacoli39sn
AT bulegenovamadina determinationofprophylacticandtherapeuticeffectivenessofprobioticstrainescherichiacoli39sn
AT kirkimbaevazhumagul determinationofprophylacticandtherapeuticeffectivenessofprobioticstrainescherichiacoli39sn
AT zhylkaidararman determinationofprophylacticandtherapeuticeffectivenessofprobioticstrainescherichiacoli39sn